Browsing by Author "Staubach, Petra"

Sort by: Order: Results:

  • Kolkhir, Pavel; Altrichter, Sabine; Asero, Riccardo; Daschner, Alvaro; Ferrer, Marta; Giménez Arnau, Anna Maria; Hawro, Tomasz; Jakob, Thilo; Kinaciyan, Tamar; Kromminga, Arno; Konstantinou, George N.; Makris, Michael; Metz, Martin; Skov, Per Stahl; Staubach, Petra; Sussman, Gordon; Zhang, Ke; Maurer, Marcus (Korean Academy of Asthma, Allergy and Clinical ImmunologyKorean Academy of Pediatric Allergy and Respiratory Disease, 2021)
    Purpose: Patients with chronic spontaneous urticaria (CSU) have an increased risk for comorbid autoimmune diseases. In this retrospective multicenter study of CSU patients, we evaluated clinical and laboratory features of ...
  • Krause, Karoline; Bonnekoh, Hanna; Jelden-Thurm, Jannis; Asero, Riccardo; Giménez Arnau, Anna Maria; Cardoso, José C.; Grattan, Clive; Kocatürk, Emek; Lippert, Undine; Maurer, Marcus; Metz, Martin; Staubach, Petra; Goncalo, Margarida; Kolkhir, Pavel (Wiley, 2023)
    Background: Urticarial vasculitis (UV) should be differentiated from chronic spontaneous urticaria (CSU) in patients initially presenting with recurrent wheals, although criteria for differential diagnosis remain ill-defined. ...
  • Weller, Karsten; Giménez Arnau, Anna Maria; Baron, Jens; Brehler, Randolf; Ferrer, Marta; Groffik, Adriane; Grundmann, Sonja; Jakob, Thilo; Labrador-Horrillo, Moisés; Müller, Sabine; Staubach, Petra; Wurpts, Gerda; Metz, Martin; Maurer, Marcus (Wiley, 2024)
    Background: Non-sedating H1 -antihistamines (nsAH) are the most commonly used treatment for chronic spontaneous urticaria (CSU). Many patients use them as on-demand (OD) therapy rather than a maintenance treatment. Here, ...
  • Giménez Arnau, Anna Maria; Maurer, Marcus; Bernstein, Jonathan A.; Staubach, Petra; Barbier, Nathalie; Hua, Eva; Severin, Thomas; Joubert, Yolandi; Janocha, Reinhold; Balp, Maria Magdalena (Wiley, 2022)
    Background: Chronic spontaneous urticaria (CSU) negatively impacts patients' sleep, thereby reducing health-related quality of life (HRQoL). Half of patients with inadequately controlled CSU report sleep interference often ...
  • Maurer, Marcus; Giménez Arnau, Anna Maria; Bernstein, Jonathan A.; Chu, Chia-Yu; Danilycheva, Inna; Hide, Michihiro; Makris, Michael; Metz, Martin; Savic, Sinisa; Sitz, Karl; Soong, Weily; Staubach, Petra; Sussman, Gordon; Barve, Avantika; Burciu, Alis; Hua, Eva; Janocha, Reinhold; Severin, Thomas (Wiley, 2022)
    Background: Ligelizumab, a next-generation, humanized anti-immunoglobulin E (IgE) monoclonal antibody is in development as a treatment for patients with chronic spontaneous urticaria, whose symptoms are inadequately ...
  • Weller, Karsten; Ohanyan, Tatevik; Hawro, Tomasz; Ellrich, André; Sussman, Gordon; Koplowitz, Jake; Giménez Arnau, Anna Maria; Peveling-Oberhag, Adriane; Staubach, Petra; Metz, Martin; Maurer, Marcus (Wiley-Blackwell, 2018)
  • Bernstein, Jonathan A.; Giménez Arnau, Anna Maria; Maurer, Marcus; Staubach, Petra; Barbier, Nathalie; Hua, Eva; Severin, Thomas; Laires, Pedro A.; Balp, Maria Magdalena (MDPI, 2023)
    This study investigated the association between urticaria activity and health-related quality of life (HRQoL). Patient evaluations from the ligelizumab Phase 2b clinical trial (N = 382) were pooled (NCT02477332). Daily ...

Search DSpace

Browse

My Account

In collaboration with Compliant to Partaking